Facilitating macromolecule delivery

Stable and targeted macromolecules to tumors

What Vector Bioscience Cambridge does

We are a University of Cambridge spin out, founded on the pioneering research in engineering nanomaterials at the Department of Chemical Engineering and Biotechnology.

We translate more than 10 years of research and applied science at Cambridge on tailoring the best nanomaterials for drug delivery applications.

More on the science, here

A video about it, here

More on the academic research, here


£2.2m EIC Transition granted 

To commercialise our RNA-based cancer therapies
Read our press release

IUK Fast Start granted

To further develop macromolecule stability
Read our press release

Star-up Festival

Insightful talks and fantastic connections
Learn more


Proud to be part of the
Accelerate Programme
Learn more


Vector participated in a Roadmapping exercise with the Institute for Manufacturing

Learn more

Get in touch